The post BTS Leaves Special Message On Apple Music For New 5th Album, ‘ARIRANG’ appeared on BitcoinEthereumNews.com. LAS VEGAS, NEVADA – APRIL 03: BTS perform onstageThe post BTS Leaves Special Message On Apple Music For New 5th Album, ‘ARIRANG’ appeared on BitcoinEthereumNews.com. LAS VEGAS, NEVADA – APRIL 03: BTS perform onstage

BTS Leaves Special Message On Apple Music For New 5th Album, ‘ARIRANG’

LAS VEGAS, NEVADA – APRIL 03: BTS perform onstage during the 64th Annual GRAMMY Awards at MGM Grand Garden Arena on April 03, 2022 in Las Vegas, Nevada. (Photo by Matt Winkelmeyer/Getty Images)

Getty Images

With the announcement of BTS’s 5th Album title, ARIRANG, the global superstars – RM, Jin, SUGA, j-hope, Jimin, V, and Jung Kook – left a message about the album on Apple Music.

When you visit the Apple Music page for BTS’s ARIRANG, there is a clip called “ARMYRANG.” In the 30-second soundbyte, leader RM leads the welcome from the group with their signature, “Here we are – BTS!”

Each member has a line to say in the message, starting with RM: “We are so excited to share our new album, ARIRANG.”

Jin continues, “This album reflects the combination of our journey to date as BTS.”

Suga follows, “And it also defines us on our own terms.”

“We’ve been waiting for this moment for a long time,” says j-hope.

Jimin then adds, “And we prepared this album thinking of our fans.”

V, in his deep voice, says, “Every track has a unique story and vibes, so we hope you enjoy all of them.”

It ends with the youngest (maknae) of the group, Jung Kook, thanking the fans, known as ARMY.

“Thank you for always being by our side,” he says. “You’re our biggest inspiration, thank you.”

The album, set to release on March 20, is said to hold a “special significance as it marks the first album released by the group in three years and nine months, while also indicating the direction the group will take going forward. The members were deeply involved in the creation of the songs, infusing their own thoughts and colors into them while musically expressing the emotions and struggles they have experienced along their journey.”

The album features 14 tracks filled with real and honest stories from the members to their fans – ARMY – as a thank you for those who have waited nearly three years for their return from their military service.

BTS’s Anticipated Comeback

BIGHIT MUSIC

ARIRANG, commonly interpreted as “my beloved one,” is a famous traditional Korean folk song and is considered the unofficial national anthem. Throughout Korean history, it has been a source of comfort, inspiration, and resistance for the country, serving as a symbol of Korea’s soul, or “Han.”

There will be four versions of the album: Rooted in Korea Ver., Rooted in Music Ver., Living Legend Ver., and the Weverse Albums ver. Each album will include photo books, photocards, posters, and collectible packaging.

There will also be vinyl versions of the album available: Modern Korea Vinyl, Group Red Vinyl, Deluxe Vinyl B&W Ver., and the seven member-based Standard Vinyl editions (RM Silver Vinyl, Jin Pink Vinyl, SUGA Clear Vinyl, j-hope Cream Vinyl, Jimin Burgundy Vinyl, V Velvet Red Vinyl, and Jung Kook Orchid Vinyl). Fans can begin pre-ordering the album on Friday, January 16, at 11 am KST (January 15, 6pm PST / 9pm EST). They can be purchased through Weverse Shop or select retailers.

Following their album release, the group – RM, Jin, Suga, j-hope, Jimin, V, and Jung Kook – will kick off their World Tour on April 9 in Goyang, South Korea, for three nights, then head to Tokyo, Japan. Their North American stops include Las Vegas, Mexico City, Baltimore, Arlington, Toronto, Chicago, Los Angeles, East Rutherford, and Foxborough. Tickets for the World Tour will go on general sale on Saturday, January 24. Those with ARMY membership can access the presales between January 22 and 23. U.S. fans can find more information here.

BTS’s 5th Album, ARIRANG, is set to release on March 20.

Source: https://www.forbes.com/sites/laurasirikul/2026/01/15/bts-leaves-special-message-on-apple-music-for-new-5th-album-arirang/

Market Opportunity
BitShares Logo
BitShares Price(BTS)
$0.001178
$0.001178$0.001178
-0.36%
USD
BitShares (BTS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23